Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater - Reck, M; Rodríguez-Abreu, D; Robinson, A (J Clin Oncol, 2019)
et al.